miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context

Abstract Background Duchenne (DMD) and Becker (BMD) muscular dystrophies are caused by mutations in the DMD gene coding for dystrophin, a protein being part of a large sarcolemmal protein scaffold that includes the neuronal nitric oxide synthase (nNOS). The nNOS was shown to play critical roles in a...

Full description

Bibliographic Details
Main Authors: Marine Guilbaud, Christel Gentil, Cécile Peccate, Elena Gargaun, Isabelle Holtzmann, Carole Gruszczynski, Sestina Falcone, Kamel Mamchaoui, Rabah Ben Yaou, France Leturcq, Laurence Jeanson-Leh, France Piétri-Rouxel
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Skeletal Muscle
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13395-018-0161-2
_version_ 1798045929478029312
author Marine Guilbaud
Christel Gentil
Cécile Peccate
Elena Gargaun
Isabelle Holtzmann
Carole Gruszczynski
Sestina Falcone
Kamel Mamchaoui
Rabah Ben Yaou
France Leturcq
Laurence Jeanson-Leh
France Piétri-Rouxel
author_facet Marine Guilbaud
Christel Gentil
Cécile Peccate
Elena Gargaun
Isabelle Holtzmann
Carole Gruszczynski
Sestina Falcone
Kamel Mamchaoui
Rabah Ben Yaou
France Leturcq
Laurence Jeanson-Leh
France Piétri-Rouxel
author_sort Marine Guilbaud
collection DOAJ
description Abstract Background Duchenne (DMD) and Becker (BMD) muscular dystrophies are caused by mutations in the DMD gene coding for dystrophin, a protein being part of a large sarcolemmal protein scaffold that includes the neuronal nitric oxide synthase (nNOS). The nNOS was shown to play critical roles in a variety of muscle functions and alterations of its expression and location in dystrophic muscle fiber leads to an increase of the muscle fatigability. We previously revealed a decrease of nNOS expression in BMD patients all presenting a deletion of exons 45 to 55 in the DMD gene (BMDd45-55), impacting the nNOS binding site of dystrophin. Since several studies showed deregulation of microRNAs (miRNAs) in dystrophinopathies, we focused on miRNAs that could target nNOS in dystrophic context. Methods By a screening of 617 miRNAs in BMDd45-55 muscular biopsies using TLDA and an in silico study to determine which one could target nNOS, we selected four miRNAs. In order to select those that targeted a sequence of 3′UTR of NOS1, we performed luciferase gene reporter assay in HEK393T cells. Finally, expression of candidate miRNAs was modulated in control and DMD human myoblasts (DMDd45-52) to study their ability to target nNOS. Results TLDA assay and the in silico study allowed us to select four miRNAs overexpressed in muscle biopsies of BMDd45-55 compared to controls. Among them, only the overexpression of miR-31, miR-708, and miR-34c led to a decrease of luciferase activity in an NOS1-3′UTR-luciferase assay, confirming their interaction with the NOS1-3′UTR. The effect of these three miRNAs was investigated on control and DMDd45-52 myoblasts. First, we showed a decrease of nNOS expression when miR-708 or miR-34c were overexpressed in control myoblasts. We then confirmed that DMDd45-52 cells displayed an endogenous increased of miR-31, miR-708, and miR-34c and a decreased of nNOS expression, the same characteristics observed in BMDd45-55 biopsies. In DMDd45-52 cells, we demonstrated that the inhibition of miR-708 and miR-34c increased nNOS expression, confirming that both miRNAs can modulate nNOS expression in human myoblasts. Conclusion These results strongly suggest that miR-708 and miR-34c, overexpressed in dystrophic context, are new actors involved in the regulation of nNOS expression in dystrophic muscle.
first_indexed 2024-04-11T23:30:04Z
format Article
id doaj.art-8dc62b062dec4a498160c96171b1ce67
institution Directory Open Access Journal
issn 2044-5040
language English
last_indexed 2024-04-11T23:30:04Z
publishDate 2018-04-01
publisher BMC
record_format Article
series Skeletal Muscle
spelling doaj.art-8dc62b062dec4a498160c96171b1ce672022-12-22T03:57:11ZengBMCSkeletal Muscle2044-50402018-04-018111310.1186/s13395-018-0161-2miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic contextMarine Guilbaud0Christel Gentil1Cécile Peccate2Elena Gargaun3Isabelle Holtzmann4Carole Gruszczynski5Sestina Falcone6Kamel Mamchaoui7Rabah Ben Yaou8France Leturcq9Laurence Jeanson-Leh10France Piétri-Rouxel11Sorbonne Université-UMRS974-Inserm-Institut de MyologieSorbonne Université-UMRS974-Inserm-Institut de MyologieSorbonne Université-UMRS974-Inserm-Institut de MyologieSorbonne Université-UMRS974-Inserm-Institut de MyologieSorbonne Université-UMRS974-Inserm-Institut de MyologieSorbonne Université-UMRS974-Inserm-Institut de MyologieSorbonne Université-UMRS974-Inserm-Institut de MyologieSorbonne Université-UMRS974-Inserm-Institut de MyologieSorbonne Université-UMRS974-Inserm-Institut de MyologieLaboratoire de Génétique et Biologie Moléculaire, Hôpital CochinGénéthonSorbonne Université-UMRS974-Inserm-Institut de MyologieAbstract Background Duchenne (DMD) and Becker (BMD) muscular dystrophies are caused by mutations in the DMD gene coding for dystrophin, a protein being part of a large sarcolemmal protein scaffold that includes the neuronal nitric oxide synthase (nNOS). The nNOS was shown to play critical roles in a variety of muscle functions and alterations of its expression and location in dystrophic muscle fiber leads to an increase of the muscle fatigability. We previously revealed a decrease of nNOS expression in BMD patients all presenting a deletion of exons 45 to 55 in the DMD gene (BMDd45-55), impacting the nNOS binding site of dystrophin. Since several studies showed deregulation of microRNAs (miRNAs) in dystrophinopathies, we focused on miRNAs that could target nNOS in dystrophic context. Methods By a screening of 617 miRNAs in BMDd45-55 muscular biopsies using TLDA and an in silico study to determine which one could target nNOS, we selected four miRNAs. In order to select those that targeted a sequence of 3′UTR of NOS1, we performed luciferase gene reporter assay in HEK393T cells. Finally, expression of candidate miRNAs was modulated in control and DMD human myoblasts (DMDd45-52) to study their ability to target nNOS. Results TLDA assay and the in silico study allowed us to select four miRNAs overexpressed in muscle biopsies of BMDd45-55 compared to controls. Among them, only the overexpression of miR-31, miR-708, and miR-34c led to a decrease of luciferase activity in an NOS1-3′UTR-luciferase assay, confirming their interaction with the NOS1-3′UTR. The effect of these three miRNAs was investigated on control and DMDd45-52 myoblasts. First, we showed a decrease of nNOS expression when miR-708 or miR-34c were overexpressed in control myoblasts. We then confirmed that DMDd45-52 cells displayed an endogenous increased of miR-31, miR-708, and miR-34c and a decreased of nNOS expression, the same characteristics observed in BMDd45-55 biopsies. In DMDd45-52 cells, we demonstrated that the inhibition of miR-708 and miR-34c increased nNOS expression, confirming that both miRNAs can modulate nNOS expression in human myoblasts. Conclusion These results strongly suggest that miR-708 and miR-34c, overexpressed in dystrophic context, are new actors involved in the regulation of nNOS expression in dystrophic muscle.http://link.springer.com/article/10.1186/s13395-018-0161-2Duchenne muscular dystrophy (DMD)Becker muscular dystrophy (BMD)miRNAnNOS
spellingShingle Marine Guilbaud
Christel Gentil
Cécile Peccate
Elena Gargaun
Isabelle Holtzmann
Carole Gruszczynski
Sestina Falcone
Kamel Mamchaoui
Rabah Ben Yaou
France Leturcq
Laurence Jeanson-Leh
France Piétri-Rouxel
miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context
Skeletal Muscle
Duchenne muscular dystrophy (DMD)
Becker muscular dystrophy (BMD)
miRNA
nNOS
title miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context
title_full miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context
title_fullStr miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context
title_full_unstemmed miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context
title_short miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context
title_sort mir 708 5p and mir 34c 5p are involved in nnos regulation in dystrophic context
topic Duchenne muscular dystrophy (DMD)
Becker muscular dystrophy (BMD)
miRNA
nNOS
url http://link.springer.com/article/10.1186/s13395-018-0161-2
work_keys_str_mv AT marineguilbaud mir7085pandmir34c5pareinvolvedinnnosregulationindystrophiccontext
AT christelgentil mir7085pandmir34c5pareinvolvedinnnosregulationindystrophiccontext
AT cecilepeccate mir7085pandmir34c5pareinvolvedinnnosregulationindystrophiccontext
AT elenagargaun mir7085pandmir34c5pareinvolvedinnnosregulationindystrophiccontext
AT isabelleholtzmann mir7085pandmir34c5pareinvolvedinnnosregulationindystrophiccontext
AT carolegruszczynski mir7085pandmir34c5pareinvolvedinnnosregulationindystrophiccontext
AT sestinafalcone mir7085pandmir34c5pareinvolvedinnnosregulationindystrophiccontext
AT kamelmamchaoui mir7085pandmir34c5pareinvolvedinnnosregulationindystrophiccontext
AT rabahbenyaou mir7085pandmir34c5pareinvolvedinnnosregulationindystrophiccontext
AT franceleturcq mir7085pandmir34c5pareinvolvedinnnosregulationindystrophiccontext
AT laurencejeansonleh mir7085pandmir34c5pareinvolvedinnnosregulationindystrophiccontext
AT francepietrirouxel mir7085pandmir34c5pareinvolvedinnnosregulationindystrophiccontext